Clinica
US bill proposes conditional clearance authority for FDA's 510(k) process
21 December 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- US FDA device reviewers to use new worksheet from 1 May to capture benefit-risk determinations
- US FDA: use of spilt predicates inconsistent with 510(k) programme
- US FDA proposes to streamline de novo medical device review pathway
- IOM report recommends abandoning US FDA 510(k) process in favour of new framework; industry concerned
Other Informa News
EVENTS
